Parsippany-based Pacira Pharmaceuticals Inc. announced Tuesday that it is offering $100 million of its common stock in a proposed public offering.
According to the release, Pacira plans to grant underwriters 30 days to purchase up to $15 million of additional shares.
Jeffries LLC, Barclays Capital Inc. and BofA Merrill Lynch are acting as the joint bookrunning managers and underwriters for the offering.
ALSO ON NJBIZ:
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy